Related Experiment Video
Updated: Oct 22, 2025
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.4K
Unmet needs in atopic dermatitis management: an expert consensus
Annalisa Patrizi1,2, Antonio Costanzo3,4, Cataldo Patruno5
1Dermatology, IRCCS S. Orsola-Malpighi Polyclinic, Bologna, Italy.
The Journal of Dermatological Treatment
|August 27, 2021
Summary
This study identified unmet needs in atopic dermatitis (AD) clinical management. Key findings highlight the need for better diagnostic criteria, prognostic tools for adult-onset AD, biomarkers, and improved patient education.
Area of Science:
- Dermatology
- Clinical Research
Background:
- Atopic dermatitis (AD) significantly impacts patient quality of life.
- Despite advances in understanding AD pathogenesis and treatment, clinical management lags behind.
- There's a need to bridge the gap between research knowledge and daily patient care.
Purpose of the Study:
- To identify unmet needs in the clinical management of atopic dermatitis.
- To achieve consensus among clinicians on key aspects of AD care.
Main Methods:
- A Delphi consensus process was employed.
- Involved an initial Steering Committee of experts, followed by a larger group of clinicians.
- Agreement was assessed across a panel of 37 Italian clinicians.
Main Results:
- 17 statements reached strong agreement, and 2 reached weak agreement among clinicians.
- Consensus identified needs for accurate diagnostic criteria, especially for atypical AD.
- Prognostic criteria for adult-onset AD and the utility of biomarkers were also highlighted.
Conclusions:
- Accurate diagnostic and prognostic criteria are crucial for effective AD management.
- Biomarkers could aid in managing AD across all disease stages.
- Enhanced patient education and supportive tools are essential for improving AD care.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
695
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
695
01:30Hypersensitivities
2.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
2.0K
01:30Asthma-IV: Diagnostic and Management
2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
01:20Asthma: Pathogenesis and Management
855
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
855
01:17Drugs Used in Lower Respiratory Disorders: Overview
721
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
721
01:19Antiasthma Drugs: Leukotriene Modifiers
701
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
701